NCBI PubMed Central
open access
Genetically modified bone marrow cells halt mitral cell loss by modulating inflammation and protecting against DNA damage.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation#1104294
- Persistent myeloid cell reprogramming despite miltefosine treatment in leishmania-infected macaques#411842
- Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma#676986
- Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient#830824
- New immune regulation strategy in the age of regenerative medicine using pluripotent stem cells#375956
Record · ID 195982
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive